Another commonly used tracer is 123I-mIBG (123I-meta-iodobenzylguanidine), a SPECT agent targeting norepinephrine transporters (NETs) that are overexpressed in neuroendocrine tumors, most notably neuroblastoma (NB) [28,29,30]. This evidence concerns the gene SLC6A2 and neuroblastoma.